WEBULL
News
SXTP
3.880
-4.20%
-0.170
Weekly Report: what happened at SXTP last week (0202-0206)?
Weekly Report · 2d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 02/02 21:05
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Aquestive Therapeutics (AQST) and 60 Degrees Pharmaceuticals, Inc. (SXTP)
TipRanks · 02/02 15:10
60 Degrees expands access to Arakoda with GoodRx partnership
TipRanks · 02/02 13:21
60 Degrees Pharmaceuticals Partners With GoodRx To Expand Access To ARAKODA
Benzinga · 02/02 13:10
60 Degrees Pharmaceuticals Partners with GoodRx to Offer Savings on Malaria Drug ARAKODA
Reuters · 02/02 13:02
60 DEGREES PHARMACEUTICALS EXPANDS ACCESS TO ARAKODA® WITH GOODRX PARTNERSHIP
Reuters · 02/02 13:01
Weekly Report: what happened at SXTP last week (0126-0130)?
Weekly Report · 02/02 10:19
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
Barchart · 02/02 07:01
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 01/28 21:05
60 Degrees Pharmaceuticals to exercise option in agreement with FSU
TipRanks · 01/28 13:11
60 Degrees Pharmaceuticals Exercises Option With Florida State University To NEgotiate License To Use Large-Scale Purification Techniques To Extract Castanospermine From Seeds Of Castanospermum Australe
Benzinga · 01/28 13:10
60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use
Barchart · 01/28 07:01
Runway Health Partnership and Multi-Pronged Commercial Strategy Underpin Buy Rating on 60 Degrees Pharmaceuticals
TipRanks · 01/27 21:15
60 Degrees Pharm Price Target Raised to $24.00/Share From $6.00 by HC Wainwright & Co.
Dow Jones · 01/27 16:45
60 Degrees Pharm Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 01/27 16:45
HC Wainwright & Co. Maintains Buy on 60 Degrees, Raises Price Target to $24
Benzinga · 01/27 16:35
60 Degrees Pharmaceuticals target adjusted to $24 at H.C. Wainwright after split
TipRanks · 01/27 16:30
What Does the Market Think About 60 Degrees Pharmaceuticals Inc?
Benzinga · 01/26 16:00
Dow Gains Over 100 Points; Steel Dynamics Posts Downbeat Earnings
Benzinga · 01/26 14:40
More
Webull provides a variety of real-time SXTP stock news. You can receive the latest news about 60 degrees pharmaceuticals, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About SXTP
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is used for malaria prevention in individuals 18 years and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.